22 projects of the cluster's young scientists were selected by an external team of reviewers.
In spring 2021, the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) invited its young scientists to submit applications for funding of research projects (so-called "miniproposals") dealing with highly innovative issues in inflammation research. From 56 applications, 22 projects were selected with the help of external reviewers to be funded by the cluster. They will each be funded with up to 50,000 euros. The selection criteria were innovation and novelty of the scientific question, methodology, relevance in relation to the topics of inflammation research, excellence in scientific thinking, and stringency in the project description. In total, the cluster funds the projects of young scientists with 856,000 euros.
"This funding offers the young researchers the opportunity to carry out their own innovative project, which otherwise would not have been possible in this way. With this, we want to specifically promote excellent research in the field of inflammation medicine by younger colleagues and support the talents in their individual research careers," says Professor Stefan Schreiber, spokesperson of PMI.
About the Cluster of Excellence PMI
The Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) is being funded from 2019 to 2025 through the German Excellence Strategy (ExStra). It succeeds the "Inflammation at Interfaces” Cluster, which was already funded in two periods of the Excellence Initiative (2007-2018). Around 300 members from eight institutions at four locations are involved: Kiel (Kiel University, University Medical Center Schleswig-Holstein (UKSH), Muthesius University of Fine Arts and Design, Kiel Institute for the World Economy (IfW), Leibniz Institute for Science and Mathematics Education (IPN)), Lübeck (University of Lübeck, University Medical Center Schleswig-Holstein (UKSH)), Plön (Max Planck Institute for Evolutionary Biology) and Borstel (Research Center Borstel - Leibniz Lung Center).
The goal is to translate interdisciplinary research findings on chronic inflammatory diseases of barrier organs to healthcare more intensively, as well as to fulfil previously unsatisfied needs of the patients. Three points are important in the context of successful treatment, and are therefore at the heart of PMI research: the early detection of chronic inflammatory diseases, the prediction of disease progression and complications, and the prediction of individual responses to treatment.